Transfusion Clinical Trials in Nanning, Guangxi
3 recruitingNanning, Guangxi, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
Transfusion Dependent Thalassemia
Rongrong Liu396 enrolled5 locationsNCT06657391
Recruiting
Early Phase 1
A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
Transfusion Dependent Beta-Thalassemia
First Affiliated Hospital of Guangxi Medical University5 enrolled1 locationNCT05762510
Recruiting
Phase 1
A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants
Transfusion Dependent Thalassemia
First Affiliated Hospital of Guangxi Medical University5 enrolled1 locationNCT05757245